Skip to content

Clinical trials

Parkinsonian Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Country / region: United States Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20044
20064
20084
20092
20101
20114
20128
20132
20146
20152
20162
20176
20181
201910
20203
20214
20228
20236
20242
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Recruiting14
Terminated11
Active, not recruiting5
Enrolling by invitation4
Unknown status4
Withdrawn3
Not yet recruiting2
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute for Neurodegenerative Disorders8
Adamas Pharmaceuticals, Inc.6
National Institute of Neurological Disorders and Stroke (NINDS)6
AbbVie4
Mayo Clinic3
Novartis Pharmaceuticals3
Bial R&D Investments, S.A.2
GE Healthcare2
National Heart, Lung, and Blood Institute (NHLBI)2
Oregon Health and Science University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders96
Parkinson Disease81
Movement Disorders24
Neurodegenerative Diseases19
Central Nervous System Diseases16
Brain Diseases15
Multiple System Atrophy12
Nervous System Diseases12
Supranuclear Palsy, Progressive12
Dyskinesias11

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.